H.C. Wainwright Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil surge keeps S&P 500, Nasdaq in check before earnings; Salesforce lifts Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| (NASDAQ: MLYS) | Delayed: 22.69 -0.68 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.37 | 52 Week High | $ | |||
| Open | $22.90 | 52 Week Low | $ | |||
| Day High | $23.10 | P/E | N/A | |||
| Day Low | $22.41 | EPS | $ | |||
| Volume | 157,784 | |||||
